Article

Coordinate linkage of HIV evolution reveals regions of immunological vulnerability

Ragon Institute of Massachusetts General Hospital, and Harvard University, Boston, MA 02129, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 06/2011; 108(28):11530-5. DOI: 10.1073/pnas.1105315108
Source: PubMed

ABSTRACT Cellular immune control of HIV is mediated, in part, by induction of single amino acid mutations that reduce viral fitness, but compensatory mutations limit this effect. Here, we sought to determine if higher order constraints on viral evolution exist, because some coordinately linked combinations of mutations may hurt viability. Immune targeting of multiple sites in such a multidimensionally conserved region might render the virus particularly vulnerable, because viable escape pathways would be greatly restricted. We analyzed available HIV sequences using a method from physics to reveal distinct groups of amino acids whose mutations are collectively coordinated ("HIV sectors"). From the standpoint of mutations at individual sites, one such group in Gag is as conserved as other collectively coevolving groups of sites in Gag. However, it exhibits higher order conservation indicating constraints on the viability of viral strains with multiple mutations. Mapping amino acids from this group onto protein structures shows that combined mutations likely destabilize multiprotein structural interactions critical for viral function. Persons who durably control HIV without medications preferentially target the sector in Gag predicted to be most vulnerable. By sequencing circulating viruses from these individuals, we find that individual mutations occur with similar frequency in this sector as in other targeted Gag sectors. However, multiple mutations within this sector are very rare, indicating previously unrecognized multidimensional constraints on HIV evolution. Targeting such regions with higher order evolutionary constraints provides a novel approach to immunogen design for a vaccine against HIV and other rapidly mutating viruses.

Download full-text

Full-text

Available from: Darrell J Irvine, Jul 04, 2015
1 Follower
 · 
113 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We study the design of portfolios under a minimum risk criterion. The performance of the optimized portfolio relies on the accuracy of the estimated covariance matrix of the portfolio asset returns. For large portfolios, the number of available market returns is often of similar order to the number of assets, so that the sample covariance matrix performs poorly as a covariance estimator. Additionally, financial market data often contain outliers which, if not correctly handled, may further corrupt the covariance estimation. We address these shortcomings by studying the performance of a hybrid covariance matrix estimator based on Tyler's robust M-estimator and on Ledoit-Wolf's shrinkage estimator while assuming samples with heavy-tailed distribution. Employing recent results from random matrix theory, we develop a consistent estimator of (a scaled version of) the realized portfolio risk, which is minimized by optimizing online the shrinkage intensity. Our portfolio optimization method is shown via simulations to outperform existing methods both for synthetic and real market data.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We describe a vaccine delivery mechanism consisting of a synthetic, non-living vector of large d,l poly(lactic-co-glycolic) acid (PLGA) microspheres that carry specific cytotoxic T lymphocyte (CTL) epitopes. We demonstrate in mice that it can be used to elicit substantial CTL responses to more than one epitope in the same individual. Our data suggest that a superior adjuvant configuration for the formulation is to place the TLR-9 agonist CpG inside the microsphere and the TLR-4 agonist MPLA in the injectate solution. This finding contrasts with the observations of others. Our approach addresses an issue that may have led to the failure of the Ad5-based HIV vaccine, in that it can elicit responses to specific epitopes thought to be protective (and exclude epitopes thought to be non-protective) by providing a means to elicit immune responses efficiently to select epitopes.
    Vaccine 06/2014; 32(33). DOI:10.1016/j.vaccine.2014.05.071 · 3.49 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This article studies two regularized robust estimators of scatter matrices proposed in parallel in (Chen et al., 2011) and (Pascal et al., 2013), based on Tyler's robust estimator (Tyler, 1987) and on Ledoit and Wolf's shrinkage covariance matrix estimator (Ledoit and Wolf, 2004). These hybrid estimators have the advantage of conveying (i) robustness to outliers or impulsive samples and (ii) small sample size adequacy to the classical sample covariance matrix estimator. We consider here the case of i.i.d. elliptical zero mean samples in the regime where both sample and population sizes are large. We demonstrate that, under this setting, the estimators under study asymptotically behave similar to well-understood random matrix models. This characterization allows us to derive optimal shrinkage strategies to estimate the population scatter matrix, improving significantly upon the empirical shrinkage method proposed in (Chen et al., 2011).
    Journal of Multivariate Analysis 01/2014; 131. DOI:10.1016/j.jmva.2014.06.018 · 0.94 Impact Factor